Ophthalmic Business News

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Alex Lopez of Ace Vision Group discusses laser scleral microporation for presbyopia.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Richard Small, CEO of Neurotech Pharmaceuticals, provides a company update ahead of the American Academy of Ophthalmology Meeting.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Anthony Wallace of Bausch + Lomb provides an update on the latest happenings at the company.

Glaukos announced that Epioxa, its next-generation corneal cross-linking iLink therapy for the treatment of keratoconus, demonstrated statistically significant improvement from baseline vs. placebo in maximum corneal curvature at 12 months.

Heidelberg Engineering obtained FDA clearance of its Spectralis Flex Module imaging platform, according to a press release.

EssilorLuxottica has completed its acquisition of an 80% stake in Heidelberg Engineering, according to a company press release.

The FDA approved the enVista Envy full range of vision IOL from Bausch + Lomb, according to a press release.

When investing, time in the market is arguably as important as well-publicized factors, such as rate of return, initial amount of investment (principal) and costs of investing.

On this episode, Laura Enyedi, MD, is live from Women in Ophthalmology discussing the sexual harassment study, surveys and results with Michelle “Mimi” Cabrera, MD, and Grace Sun, MD.

Clobetasol propionate ophthalmic suspension 0.05% for postoperative inflammation and pain after ocular surgery is now commercially available in the U.S., according to a press release from Eyenovia.